Genetic variations of Mrf-2/Arid5b confer risk of coronary atherosclerosis in the Japanese population

International Heart Journal

Volumn 49, Issue 3, 2008, Pages 313-327

  Wang, Guoqin ^a   Watanabe, Masafumi ^a   Imai, Yasushi ^a   Hara, Kazuo ^a   Manabe, Ichiro ^a   Maemura, Koji ^a   Horikoshi, Momoko ^a   Kohro, Takahide ^a   Amiya, Eisuke ^a   Sugiyama, Takao ^b   Fujita, Takeshi ^c   Kadowaki, Takashi ^a   Yamazaki, Tsutomu ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b INSTITUTE FOR ADULT DISEASES   (Japan)

^c HITACHI LTD   (Japan)

Author keywords

ARID5B; Atherosclerosis; Coronary artery disease; Genetic risk factors; Mrf 2; Polymorphism

Indexed keywords

AT RICH INTERACTION DOMAIN 5B PROTEIN; GUANINE; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; HYPOTHESIS; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; ANIMALS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; JAPAN; MALE; MICE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 49449115323     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.313     Document Type: Article

References (38)

1. Mälarstig A, Tenno T, Johnston N, et al. Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol 2005; 25: 2667-72.
2. Yamada Y. Identification of genetic factors and development of genetic risk diagnosis systems for cardiovascular diseases and stroke. Circ J 2006; 70: 1240-8.
3. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell 2001; 104: 503-16. (Review)
4. Watanabe M, Layne MD, Hsieh CM, et al. Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2alpha and Mrf2beta. Circ Res 2002; 91: 382-9.
5. Herrscher RF, Kaplan MH, Lelsz DL, Das C, Scheuermann R, Tucker PW. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev 1995; 9: 3067-82.
6. Christiansen H, Hansen AC, Vijn I, et al. A novel type of DNA-binding protein interacts with a conserved sequence in an early nodulin ENOD12 promoter. Plant Mol Biol 1996; 32: 809-21.
7. Gregory SL, Kortschak RD, Kalionis B, Saint R. Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins. Mol Cell Biol 1996; 16: 792-9.
8. Ristevski S, Tam PP, Kola I, Hertzog P. Desrt, an AT-rich interaction domain family transription factor gene, is an early marker for nephrogenic mesoderm and is expressed dynamically during mouse limb development. Mech Dev 2001; 104: 139-42.
9. Takemura Y, Osuga Y, Yamauchi T, et al. Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology 2006; 147: 3203-10.
10. Wilsker D, Patsialou A, Dallas PB, Moran E. ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ 2002; 13: 95-106. (Review)
11. Shandala T, Kortschak RD, Saint R. The Drosophila retained/dead ringer gene and ARID gene family function during development. Int J Dev Biol 2002; 46: 423-30.
12. Shandala T, Takizawa K, Saint R. The dead ringer/retained transcriptional regulatory gene is required for positioning of the longitudinal glia in the Drosophila embryonic CNS. Development 2003; 130: 1505-13.
13. Lahoud MH, Ristevski S, Venter DJ, et al. Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res 200l; 11: 1327-34.
14. Whitson RH, Tsark W, Huang TH, Itakura K. Neonatal mortality and leanness in mice lacking the ARID transcription factor Mrf-2. Biochem Biophys Res Commun 2003; 312: 997-1004.
15. Horikoshi M, Hara K, Ohashi J, et al. A polymorphism in the AMPKalpha2 subunit gene is associated with insulin resistance and type 2 diabetes in the Japanese population. Diabetes 2006; 55: 919-23.
16. Nakai K, Habano W, Fujita T, et al. Highly multiplexed genotyping of coronary artery disease-associated SNPs using MALDI-TOF mass spectrometry. Hum Mutat 2002; 20: 133-8.
17. Tan Q, Christiansen L, Christensen K, et al. Haplotype association analysis of human disease waits using genotype data of unrelated individuals. Grenet Res 2005; 86: 223-31.
18. Purcell S, Daly MJ, Sham PC. WHAP: Implotype-based association analysis. Bioinformatics 2007; 23: 255-6.
19. Moon JY, Kwon HM, Kwon SW, et al. Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease, cardiology 2007; 108: 282-9.
20. Gensini GG. A more meaningful system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
21. Gorlin 1L Dynamic vascular factors in the genesis of myocardial ischemia. J Am Coll Cardiol 1983; 1: 897-906. (Review)
22. Meade TW. Fibrinogen in ischaemic heart disease. Eur Heart J 1995; 16 Suppl A: 31-4. (Review)
23. Wiviott SD, Michelson AD, Berger PB, Lepor NE, Kereiakes DJ. Therapeutic goals for effective platelet inhibition: a consensus document. Rev Cardiovasc Med 2006; 7: 214-25. (Review)
24. Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD. A study of twins and stroke. Stroke 1992; 23: 221-3.
25. Sørensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727-32.
26. Jones A, Dhamrait SS, Payne JR, et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension 2003; 42: 500-6.
27. Alvarez R, Reguero JR, Batalla A, Iglesias-Cubero G, Cortina A, Alvarez V, Coto E. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res 1998; 40: 375-9.
28. Tsai CT, Hwang JJ, Ritchie MD, et al. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 2007; 195: 172-80.
29. Toyofuku M, Imazu M, Sumii K, et al. Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention. Atherosclerosis 2002; 160: 339-44.
30. Petrovic D, Peterlin B. Pharmaacogenomic considerations of the insertion/ deletion gene polymorphism of the angiotensin I-converting enzyme and coronary artery disease. Curr Vasc Pharmacol 2004; 2: 271-9. (Review)
31. Jeunemaitre X, Ledru F, Battaglia S, et al. Genetic polymorphisms of the renin-angiotensin system mad angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet 1997; 99: 66-73.
32. Ulgen MS, Ozturk O, Yazici M, et al. Association between A/C1166 gene polymorphism of the angiotensin II type 1 receptor and biventricular functions in patients with acute myocardial infarction. Circ J 2006; 70: 1275-9.
33. Brscic E, Bergerone S, Gagnor A, et al. Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme, magiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up. Am Heart J 2000; 139: 979-84.
34. Petrovic D, Zorc M, Kanic V, Peterlin B. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction. Angiology 2001; 52: 247-52.
35. Kajimoto K, Shioji K, Tago N, et al. Assessment of MEF2A mutations in myocardial infarction in Japanese patients. Circ J 2005; 69: 1192-5.
36. Wang L, Fan C, Topol SE, Topol EJ, Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003; 302: 1578-81.
37. Bhagavatula MR, Fan C, Shen GQ, et al. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet 2004; 13: 3181-8.
38. Wang Q, Rao S, Topol EJ. Miscues on the "lack of MEF2A mutations" in coronary artery disease. J Clin Invest 2005; 115: 1399-400.